期刊
FASEB JOURNAL
卷 27, 期 1, 页码 45-50出版社
FEDERATION AMER SOC EXP BIOL
DOI: 10.1096/fj.12-211730
关键词
vascular endothelial growth factor; hypoxia-inducible factor 1 alpha; extracellular signal-regulated kinase
资金
- U.S. National Institutes of Health [R01 CA118764, P01 CA045548]
- JoAnn Webb Fund for Angiogenesis Research
- S. Elizabeth O'Brien Trust
- Advanced Medical Foundation
- Breast Cancer Research Foundation
- NATIONAL CANCER INSTITUTE [P01CA045548, R01CA118764] Funding Source: NIH RePORTER
Lipocalin 2 (Lcn2), a member of the lipocalin family, is up-regulated in a variety of epithelial cancers. We have previously reported that Lcn2 induces the epithelial to mesenchymal transition in breast cancer through the estrogen receptor alpha/Slug axis and that it is a potential noninvasive biomarker of this disease. Here, we report the novel finding that Lcn2 regulates breast cancer angiogenesis. Vascular endothelial growth factor (VEGF), a key angiogenic activator, was significantly increased with Lcn2 expression in MCF-7 human breast cancer cells as well as in an angiogenic line derived from MDA-MB-436 cells. Treatment with a VEGF-neutralizing antibody demonstrates that VEGF is essential for the angiogenic activity of Lcn2. We further demonstrate that Lcn2-induced VEGF is mediated through hypoxia-inducible factor 1 alpha (HIF-1 alpha) and that Lcn2 regulates HIF-1 alpha through extracellular signal-regulated kinase (Erk). The regulation of HIF-1 alpha and VEGF by Lcn2 was also demonstrated in the aggressive MDA-MB-231 cell line. Using the mouse corneal pocket assay, we found that Lcn2 significantly enhanced the angiogenesis induced by VEGF. Taken together, these results are the first to demonstrate that Lcn2 promotes angiogenesis in vitro and in vivo and suggest a novel mechanism through which Lcn2 may promote tumor progression.-Yang, J., McNeish, B., Butterfield, C., Moses, M. A. Lipocalin 2 is a novel regulator of angiogenesis in human breast cancer. FASEB J. 27, 45-50 (2013). www.fasebj.org
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据